Gynecomastia due to hormone therapy for advanced prostate cancer: A report of ten surgically treated cases and a review of treatment options

Tumori

Volumn 90, Issue 4, 2004, Pages 410-415

  Prezioso, Domenico ^a   Piccirillo, Giuseppe ^a   Galasso, Raffaele ^a   Altieri, Vincenzo ^a   Mirone, Vincenzo ^a   Lotti, Tullio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Gynecomastia; Gynecomastia and antiandrogens; Gynecomastia and antiestrogens; Gynecomastia and aromatase inhibitors; Gynecomastia and hormone therapy; Gynecomastia and mastectomy; Gynecomastia and prostate cancer; Gynecomastia and radiation therapy

Indexed keywords

ANTIANDROGEN; ANTIESTROGEN; AROMATASE INHIBITOR; BICALUTAMIDE; ESTROGEN;

ADULT; AGED; BREAST TENDERNESS; CANCER HORMONE THERAPY; CLINICAL ARTICLE; DISEASE COURSE; GYNECOMASTIA; HEMATOMA; HISTOPATHOLOGY; HUMAN; LIPOSUCTION; MALE; MASTALGIA; MASTECTOMY; MONOTHERAPY; PROSTATE CANCER; REVIEW; SEROMA; SURGICAL TECHNIQUE;

EID: 4644350355     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160409000409     Document Type: Review

References (39)

1. Pirke KM, Doerr P: Age related changes in free plasma testosterone, dihydrotestosterone and oestradiol. Acta Endocrinol, 80: 171-178, 1975.
2. Nuttal FQ: Gynecomastia as a physical finding in normal men. J Clin Endocrinol Metab, 48: 338-340, 1979.
3. Braunstein GD: Gynecomastia. N Engl J Med, 328: 490-495, 1993.
4. Boccardo F, Rubagotti A, Barichello M: Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients: results of an Italian Prostate Cancer Project study. J Clin Oncol, 17: 2027-2038, 1999.
5. Fourcade RO, Auxerre CC, Poterre M: An open multicentre randomised study to compare the effect and safety of Casodex (bicalutamide) monotherapy with castration plus nilutamide in metastatic prostate cancer (abst 349). Eur Urol, 33 (Suppl 1): 88, 1998.
6. Anonymous: Leuprolide versus diethylstilbestrol for metastatic prostate cancer. The Leuprolide Study Group. N Engl J Med, 311: 1281-1286, 1984.
7. Crawford ED, Eisenberger MA, McLeod DG, Spaulding JT, Benson R, Dorr FA, Blumenstein BA, Davis MA, Goodman PJ: A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med, 321: 419-424, 1989.
8. Tyrrell CJ: Tolerability and quality of life aspects with the anti-androgen Casodex (ICI 176, 334) as monotherapy for prostate cancer. International Casodex Investigators. Eur Urol 26 (Suppl 1): 15-19, 1994.
9. Verhelst J, Denis L, Van Vliet P, Van Poppel H, Braeckman J, Van Cangh P, Mattelaer J, D'Hulster D, Mahler C: Endocrine profiles during administration of the new non-steroidal antiandrogen Casodex in prostate cancer. Clin Endocrinol (Oxf), 41: 525-530, 1994.
10. Iversen P, Tyrrell CJ, Kaisary AV, Anderson JB, Van Poppel H, Tammela TL, Chamberlain M, Carroll K, Melezinek I: Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of follow-up. J Urol, 164: 1579-1582, 2000.
11. Decensi AU, Boccardo F, Guameri D, Positano N, Paoletti MC, Costantini M, Martorana G, Giullani L: Monotherapy with nilutamide, a pure non-steroidal antiandrogen, in untreated patients with metastatic carcinoma of the prostate. The Italian Prostatic Cancer Project. J Urol, 146: 377-381, 1991.
12. Chang A, Yeap B, Davis T, Blum R, Hahn R, Khanna O, Fisher H, Rosenthal J, Witte R, Schinella R, Trump D: Double-blind, randomised study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol. J Clin Oncol, 14: 2250-2257, 1996.
13. Boccon-Gibod L, Foumier G, Bottet P, Marechal JM, Guiter J, Rischman P, Hubert J, Soret JY, Mangin P, Mallo C, Fraysse CE: Flutamide versus orchidectomy in the treatment of metastatic prostate carcinoma. Eur Urol, 32: 391-396, 1997.
14. Tyrrell CJ: Gynaecomastia: aetiology and treatment options. Prost Cancer Prost Dis, 2: 167-171, 1999.
15. McLeod DG, Iversen P: Gynecomastia in patients with prostate cancer: a review of treatment options. Urology, 56: 713-720, 2000.
16. Saltzstein D, Cantwell A, Steber P, Ross JR, Silvay-Mandeau O, Gallo J: Prophylactic tamoxifen significantly reduces the incidence of Bicalutamide-induced gynaecomastia and breast pain. Br J Urol, 90: 120-121, abstract PD-4.07, 2002.
17. Alagaratnam TT: Idiopathic gynecomastia treated with tamoxifen: a preliminary report. Clin Ther, 9: 483-487, 1987.
18. McDermott MT, Hofeldt FD, Kidd GS: Tamoxifen therapy for painful idiopathic gynaecomastia. South Med J, 83: 1283-1285, 1990.
19. Parker LN, Gray DR, Lai MK, Levin ER: Treatment of gynaecomastia with tamoxifen: a double-blind crossover study. Metabolism, 35: 705-708, 1986.
20. Serels S, Melman A: Tamoxifen as treatment for gynecomastia and mastodynia resulting from hormonal deprivation. J Urol, 159: 1309, 1998.
21. Staiman VR, Lowe FC: Tamoxifen for flutamide/finasteride-induced gynecomastia. Urology, 50: 929-933, 1997.
22. Bocerdo F, Rubagotti A, Garofalo L, Di Tonno P, Conti G, Bertaccini A, De Antoni P, Galassi P: Tamoxifen is more effective than anastrazole in preventing gynaecomastia induced by bicalutamide monotherapy in prostate cancer patients. Proc ASCO, 22: 400 (abst 1608), 2003.
23. Braunstein GD: Aromatase and gynecomastia. Endocr Relat Cancer, 6:315-324, 1999.
24. Donati L, Grappolini G, Ponzielli M, Colonna M, Capretti A: Surgical treatment of gynaecomastia. Indications and methods (in Italian). Minerva Chir, 48: 743-747, 1993.
25. Chou JL, Easley JD, Feldmeier JJ, Rauth VA, Pomeroy TC: Effective radiotherapy in palliating mammalgia associated with gyecomastia after DES therapy. Int J Radiat Oncol Biol Phys, 15: 749-751, 1988.
26. Pass D, Steinfeld A, Brown J, Tessler A: Radiotherapeutic prophylaxis of estrogen-induced gynecomastia: a study of late sequela. Int J Radiat Oncol Biol Phys, 12: 407-408, 1986.
27. Widmark AJ, Damber L, Fossa SD, Lundmo P, Damber JE, Klepp O: Does prophylactic radiotherapy prevent antiandrogen induced gynaecomastia? Evaluation of patients in the randomised Scandinavian trial SPCG7/SFUO-3. Int J Rad Oncol Biol Phys, 45 (Suppl): 262-263 (abst 1010), 1999.
28. Simon BE, Hoffman S, Kahn S: Classification and surgical correction of gynecomastia. Plast Reconstr Surg, 51: 48-52, 1973.
29. Webster JP: Mastectomy for gynaecomastia through a semicircular intra-areolar incision. Ann Surg, 124: 557-575, 1946.
30. Letterman G, Schutter M: The surgical correction of gynecomastia. Am Surg, 35: 322-325, 1969.
31. Saad MN, Kay S: The circumareolar incision: a useful incision for gynaecomastia. Ann R Coll Surg Engl, 66: 121-122, 1984.
32. Colombo-Benkmann M, Buse B, Stern J, Herfarth C: Indications for and results of surgical therapy for male gynaecomastia. Am J Surg, 178: 60-63, 1999.
33. Pitanguy I: Transareolar incision for gynaecomastia. Plast Reconstr Surg, 38: 414-419, 1966.
34. Rosenberg GJ: Gynecomastia: suction lipectomy as a contemporary solution. Plast Reconstr Surg , 80: 379-386, 1987.
35. Samdal F, Kleppe G, Amland PF: Surgical treatment of gynaecomastia. Five years experience with liposuction. Scand J Reconstr Surg Hand Surg, 28: 123-130, 1994.
36. Gangai MP, Shown TE, Sieber PE, Moore CA: External irradiation: a successful modality in preventing hormonally induced gynaecomastia. J Urol, 97: 338-339, 1967.
37. Malis I, Cooper F, Wolever THS: Breast irradiation in patients with carcinoma of the prostate. J Urol, 102: 336-337, 1969.
38. Wolf H, Madsen PO, Vermund H: Prevention of estrogen-induced gynaecomastia by external irradiation. J Urol, 102: 607-609, 1969.
39. Zachmann M, Eiholzer U, Muritano M: Treatment of pubertal gynaecomastia with testolactone. Acta Endocrinol, 279: 218-226, 1986.